Literature DB >> 28360720

Electroneuromyographic Features in Fabry Disease: A Retrospective Review.

Çetin Kürşad Akpinar1, Hande Türker2, Oytun Bayrak2, Nilgün Cengiz2.   

Abstract

INTRODUCTION: Fabry disease (FD) is an X-linked recessive inherited disorder characterized by lysosomal alpha-galactosidase deficiency. The purpose of our study was to assess and compare the electroneuromyographic (ENMG) findings of 15 patients with Fabry disease and the electroneurographic (ENG) findings of 15 healthy controls. We have not encountered any similar study in the medical literature of our country. Therefore, we believe that our study will contribute to national literature.
METHODS: Fifteen patients with Fabry disease, 13 females and 2 males and 15 healthy controls, 13 females and 2 males, were included in the study. The definite diagnosis of patients with Fabry disease was made based on the enzyme level and genetic mutation. The patients with Fabry disease were examined with ENMG, while the healthy control group was examined with ENG. In the patients with a normal ENMG examination, neuropathic pain was attributed to the small fiber involvement.
RESULTS: Patients with Fabry disease had neuropathic pain (LANSS score≥12). While neurological examination was normal in eight patients, glove- and stocking-type hypoesthesia and decreased deep tendon reflexes were observed in five and two patients, respectively. Axonal polyneuropathy was detected in one patient. The ENMG examinations of the other patients were normal. Enzyme replacement therapy could not be initiated in one patient because of pregnancy. The neurological examination of the healthy control group was normal. There was no statistically significant difference between the ENMG features of both groups (p>.05). As in other studies, a routine ENMG examination was normal in our patients with early-stage Fabry disease. Neuropathic pain, seen in patients with Fabry disease in literature, is thought to be due to small fiber involvement.
CONCLUSION: Fabry disease should be considered in the differential diagnosis of patients with neuropathic pain at young ages. It should be kept in mind that ENMG examination can be normal at the early stages. Quantitative sensory test, autonomic tests (R-R interval and sympathetic skin response) and skin biopsy should be performed in such cases. In our country, pediatric physicians work on Fabry disease more than physicians dealing with Fabry disease in adults. Therefore, in this retrospective study, we aimed to draw adult and pediatric neurologists' attention to Fabry disease.

Entities:  

Keywords:  Electroneuromyography; Fabry disease; small fiber neuropathy

Year:  2015        PMID: 28360720      PMCID: PMC5353058          DOI: 10.5152/npa.2015.7646

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  22 in total

1.  Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

Authors:  Raphael Schiffmann; Mary Kay Floeter; James M Dambrosia; Surya Gupta; David F Moore; Yehonatan Sharabi; Ramesh K Khurana; Roscoe O Brady
Journal:  Muscle Nerve       Date:  2003-12       Impact factor: 3.217

Review 2.  Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype.

Authors:  G A Ashley; J Shabbeer; M Yasuda; C M Eng; R J Desnick
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

3.  Small fiber dysfunction predominates in Fabry neuropathy.

Authors:  M Dütsch; H Marthol; B Stemper; M Brys; T Haendl; M J Hilz
Journal:  J Clin Neurophysiol       Date:  2002-12       Impact factor: 2.177

4.  Loss of small peripheral sensory neurons in Fabry disease. Histologic and morphometric evaluation of cutaneous nerves, spinal ganglia, and posterior columns.

Authors:  A Onishi; P J Dyck
Journal:  Arch Neurol       Date:  1974-08

5.  Fabry's disease on the mechanism of the peripheral nerve involvement.

Authors:  N Fukuhara; M Suzuki; N Fujita; T Tsubaki
Journal:  Acta Neuropathol       Date:  1975-10-27       Impact factor: 17.088

6.  Small fiber neuropathy in female patients with fabry disease.

Authors:  Rocco Liguori; Vitantonio Di Stasi; Enrico Bugiardini; Renzo Mignani; Alessandro Burlina; Walter Borsini; Agostino Baruzzi; Pasquale Montagna; Vincenzo Donadio
Journal:  Muscle Nerve       Date:  2010-03       Impact factor: 3.217

7.  Nerve conduction studies, electromyography and sympathetic skin response in Fabry's disease.

Authors:  Irenio Gomes; Daniel B Nora; Jefferson Becker; João Arthur C Ehlers; Ida V D Schwartz; Roberto Giugliani; Patricia Ashton-Prolla; Laura Jardim
Journal:  J Neurol Sci       Date:  2003-10-15       Impact factor: 3.181

Review 8.  Fabry's disease.

Authors:  Yuri A Zarate; Robert J Hopkin
Journal:  Lancet       Date:  2008-10-18       Impact factor: 79.321

9.  Neurology of Fabry disease.

Authors:  M Low; K Nicholls; N Tubridy; P Hand; D Velakoulis; L Kiers; P Mitchell; G Becker
Journal:  Intern Med J       Date:  2007-07       Impact factor: 2.048

Review 10.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

View more
  1 in total

1.  Altered pupillary light responses are associated with the severity of autonomic symptoms in patients with Fabry disease.

Authors:  Gulfidan Bitirgen; Kultigin Turkmen; Nazmi Zengin; Rayaz A Malik
Journal:  Sci Rep       Date:  2021-04-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.